Bertrand Loy
Bertrand Loy's purchase track record
Bertrand Loy has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/26/2022 | HBIO | $32K | -26.8% | -10.3% | -2.2% |
| 8/18/2022 | HBIO | $163K | -26.4% | -4.4% | -4.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Entegris Shares Gain After Analysts Adopt More Constructive View. Analysts have shifted to a more positive outlook on Entegris, lifting its fair‑value estimate modestly. The stock, however, fell along with other semiconductor names such as Micron and AMD, reflecting broader sector weakness. The lift comes amid a broader rebound in the semiconductor sector after a recent dip, but the price remains below the 200‑day moving average.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Harvard Bioscience Forms Scientific Advisory Board. Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.
Transaction History
| ITT | ▲ Buy | Grant | 756 | $0 | 8/1/2026 | View on chart |
| ENTG | ▲ Buy | Option Exercise | 44,138 | $4.3M | 4/17/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 44,138 | $6.4M | 4/17/2026 | View on chart |
| ENTG | ▲ Buy | Option Exercise | 17,396 | $1.7M | 4/14/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 17,396 | $2.4M | 4/14/2026 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 9,868 | $1.1M | 4/5/2026 | View on chart |
| ENTG | ▲ Buy | Grant | 19,628 | $0 | 4/1/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 46,522 | $6.4M | 2/25/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 3,800 | $527K | 2/25/2026 | View on chart |
| ENTG | ▲ Buy | Option Exercise | 9,838 | $965K | 2/24/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 6,955 | $977K | 2/24/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 2,783 | $394K | 2/24/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 100 | $14K | 2/24/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 47,611 | $6.6M | 2/24/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 2,067 | $288K | 2/24/2026 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 15,149 | $2.0M | 2/19/2026 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 8,130 | $1.1M | 2/19/2026 | View on chart |
| ENTG | ▲ Buy | Grant | 34,624 | $0 | 2/19/2026 | View on chart |
| ENTG | ▲ Buy | Option Exercise | 65,250 | $3.6M | 2/2/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 200 | $23K | 2/2/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 2,412 | $283K | 2/2/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 9,292 | $1.1M | 2/2/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 16,424 | $2.0M | 2/2/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 34,522 | $4.2M | 2/2/2026 | View on chart |
| ENTG | ▼ Sell | Open Market | 2,400 | $290K | 2/2/2026 | View on chart |
| ENTG | ▲ Buy | Option Exercise | 57,570 | $1.9M | 12/1/2025 | View on chart |
| ENTG | ▼ Sell | Open Market | 40,865 | $3.2M | 12/1/2025 | View on chart |
| ENTG | ▼ Sell | Open Market | 16,360 | $1.2M | 12/1/2025 | View on chart |
| ENTG | ▼ Sell | Open Market | 345 | $27K | 12/1/2025 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 4,619 | $302K | 4/5/2025 | View on chart |
| ENTG | ▲ Buy | Grant | 54,060 | $0 | 4/1/2025 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 6,127 | $662K | 2/20/2025 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 12,932 | $1.4M | 2/20/2025 | View on chart |
| ENTG | ▲ Buy | Grant | 12,671 | $0 | 2/19/2025 | View on chart |
| ENTG | ▲ Buy | Option Exercise | 27,044 | $841K | 7/3/2024 | View on chart |
| ENTG | ▼ Sell | Open Market | 19,509 | $2.7M | 7/3/2024 | View on chart |
| ENTG | ▼ Sell | Open Market | 7,035 | $995K | 7/3/2024 | View on chart |
| ENTG | ▼ Sell | Open Market | 500 | $71K | 7/3/2024 | View on chart |
| HBIO | ▲ Buy | Grant | 56,575 | $0 | 5/21/2024 | View on chart |
| ENTG | ▲ Buy | Grant | 38,208 | $0 | 4/1/2024 | View on chart |
| ENTG | ▲ Buy | Grant | 20,534 | $0 | 2/20/2024 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 9,107 | $1.2M | 2/20/2024 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 15,756 | $2.2M | 2/16/2024 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 9,357 | $897K | 8/15/2023 | View on chart |
| HBIO | ▲ Buy | Grant | 31,516 | $0 | 5/22/2023 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 14,126 | $1.2M | 2/17/2023 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 8,727 | $741K | 2/13/2023 | View on chart |
| ENTG | ▲ Buy | Grant | 19,676 | $0 | 2/13/2023 | View on chart |
| ENTG | ▲ Buy | Grant | 51,292 | $0 | 1/31/2023 | View on chart |
| HBIO | ▼ Sell | Other | 108,715 | $0 | 9/6/2022 | View on chart |
| HBIO | ▲ Buy | Open Market | 9,291 | $32K | 8/26/2022 | View on chart |
| HBIO | ▲ Buy | Open Market | 8,244 | $28K | 8/25/2022 | View on chart |
| HBIO | ▲ Buy | Open Market | 17,291 | $56K | 8/24/2022 | View on chart |
| HBIO | ▲ Buy | Open Market | 8,939 | $29K | 8/23/2022 | View on chart |
| HBIO | ▲ Buy | Open Market | 4,918 | $16K | 8/22/2022 | View on chart |
| HBIO | ▲ Buy | Open Market | 9,608 | $32K | 8/19/2022 | View on chart |
| HBIO | ▲ Buy | Open Market | 1,151 | $4K | 8/18/2022 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 9,357 | $986K | 8/15/2022 | View on chart |
| ENTG | ▲ Buy | Grant | 116 | — | 7/6/2022 | View on chart |
| HBIO | ▲ Buy | Grant | 47,493 | $0 | 5/24/2022 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 15,043 | $2.0M | 2/18/2022 | View on chart |
| ENTG | ▼ Sell | Tax Withholding | 10,653 | $1.3M | 2/11/2022 | View on chart |
| ENTG | ▲ Buy | Grant | 24,020 | $0 | 2/11/2022 | View on chart |
| ENTG | ▲ Buy | Grant | 27,248 | $0 | 2/1/2022 | View on chart |
| HBIO | ▲ Buy | Grant | 4,489 | $0 | 1/1/2022 | View on chart |
| HBIO | ▲ Buy | Grant | 1,401 | $0 | 12/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
ITT Announces Q3 2026 Earnings Release; Conglomerates Lag Behind
ITT has set a date for its third‑quarter 2026 earnings release and conference call. Analysts are comparing ITT to MITSY to assess value, while a recent Yahoo piece notes that conglomerate stocks are trailing ITT this year. The company’s focus on expanding its flow business could strengthen its core operations.
ITT Announces Q3 2026 Earnings Release; Conglomerates Lag Behind. ITT has set a date for its third‑quarter 2026 earnings release and conference call. Analysts are comparing ITT to MITSY to assess value, while a recent Yahoo piece notes that conglomerate stocks are trailing ITT this year. The company’s focus on expanding its flow business could strengthen its core operations.